In patients with ulcerative colitis exposed to anti-TNF therapy, tofacitinib is linked to higher rates of clinical and ...
ASCENTRA-UC expected to enroll up to 204 patients with moderately to severely active ulcerative colitis across North America ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 3 ATLAS-UC induction-only study (Study 2) evaluating tulisokibart ...
U.S.-listed shares of Abivax climbed more than 25% in after-hours trading after the French biotech released new data aimed at ...
Hosted on MSN
Abivax hits 'best-case' scenario for ulcerative colitis drug; so, why did shares plummet?
AbivaxABVX stock crashed by more than a third Tuesday despite what one analyst called "best-case" results for a study of its ulcerative colitis treatment after several patients developed cancer. At ...
Ulcerative colitis is a chronic condition that affects the large intestines, particularly the colon. It is classified as one of the two inflammatory bowel diseases along with Crohn’s disease. The ...
'Imagine having a wound that never heals. Only it’s on the inside and every time you eat or drink, it’s like rubbing salt into that wound.' When asked to explain the sensation of ulcerative colitis, ...
Our gut is the key to much of our body's overall health, which is why diseases like ulcerative colitis can be so detrimental. Ulcerative colitis is one of the most common inflammatory bowel diseases.
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that affects the large intestine, causing persistent inflammation in the colon and rectum. The condition typically begins in the rectum ...
If you find yourself shaking your fists at the sky, demanding to know the truth behind the causes of ulcerative colitis (UC), you’ve probably had your fair share of less-than-pleasant bathroom time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results